250 Participants Needed

Blood Draw for Non-Healing Wounds in Diabetes

(WoundVac Trial)

Recruiting at 2 trial locations
TG
AM
BH
KD
JV
PD
Overseen ByPiya Das Ghatak, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Sashwati Roy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores why wound healing is slower in people with diabetes compared to those without. By examining blood and wound cells from both diabetic and non-diabetic participants with chronic wounds, researchers aim to uncover the reasons behind ongoing inflammation in diabetic wounds. Participants with a chronic wound lasting more than four weeks, regardless of diabetes status, are needed. As an unphased study, this trial offers participants the chance to contribute to groundbreaking research that could lead to better treatments for chronic wounds.

Do I need to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to uncover why people with diabetes often have trouble healing wounds. While most treatments for diabetic wounds focus on managing infections and improving blood flow, this study takes a different angle by analyzing blood samples to understand the underlying mechanisms at play. By identifying specific factors in the blood that affect healing, researchers hope to pave the way for new, more effective treatments in the future. This approach could lead to breakthroughs that not only speed up healing but also improve overall outcomes for diabetic patients.

Who Is on the Research Team?

SR

Sashwati Roy, Ph.D.

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

Inclusion Criteria

Ages 21-80
Chronic Wound (present >4 weeks)
Diabetic & Non-diabetic
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Study of biology of wound derived inflammatory cells and fluid from diabetic versus non diabetic wounds

16 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Blood draw

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Diabetic wound studyExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Sashwati Roy

Lead Sponsor

Trials
3
Recruited
390+

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

Dr. Sashwati Roy

Lead Sponsor

Trials
1
Recruited
250+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security